Log in to save to my catalogue

Lactoferrin for the treatment of COVID‑19 (Review)

Lactoferrin for the treatment of COVID‑19 (Review)

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7664603

Lactoferrin for the treatment of COVID‑19 (Review)

About this item

Full title

Lactoferrin for the treatment of COVID‑19 (Review)

Publisher

Greece: Spandidos Publications

Journal title

Experimental and therapeutic medicine, 2020-12, Vol.20 (6), p.1-1

Language

English

Formats

Publication information

Publisher

Greece: Spandidos Publications

More information

Scope and Contents

Contents

The coronavirus disease 2019 (COVID-19) outbreak was caused by infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The clinical outcomes of elderly individuals and those with underlying diseases affected by COVID-19 are serious, and may result in acute respiratory distress syndrome (ARDS) and even mortality. Currently,...

Alternative Titles

Full title

Lactoferrin for the treatment of COVID‑19 (Review)

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7664603

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7664603

Other Identifiers

ISSN

1792-0981

E-ISSN

1792-1015

DOI

10.3892/etm.2020.9402

How to access this item